Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Immunization of ducks for type C botulism.

R Martinez1, G Wobeser

  • 1Department of Veterinary Pathology, Western College of Veterinary Medicine, University of Saskatchewan, Saskatoon, Canada.

Journal of Wildlife Diseases
|November 26, 1999
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Renal coccidiosis in wild ducks in Saskatchewan.

Journal of wildlife diseases·2013
Same author

Dermoid cysts in caribou.

Journal of wildlife diseases·2009
Same author

Excretion of pathogenic Newcastle disease virus by double-crested cormorants (Phalacrocorax auritus) in absence of mortality or clinical signs of disease.

Avian pathology : journal of the W.V.P.A·2008
Same author

Tularemia in deer mice (peromyscus maniculatus) during a population irruption in Saskatchewan, Canada.

Journal of wildlife diseases·2007
Same author

Demographic features of Bartonella infections in Richardson's ground squirrels (Spermophilus richardsonii).

Journal of wildlife diseases·2007
Same author

Effect of experimental ectoparasite control on bartonella infections in wild Richardson's ground squirrels.

Journal of wildlife diseases·2007

A vaccine for ranch mink against type C botulism provided protection to ducks. Immunization may aid in treating botulism outbreaks in birds.

Area of Science:

  • Veterinary Medicine
  • Toxicology
  • Immunology

Background:

  • Botulism poses a significant threat to wild waterfowl populations.
  • Type C botulism is a common cause of mortality in birds.
  • Existing vaccines are primarily developed for terrestrial animals.

Purpose of the Study:

  • To evaluate the efficacy of a type C botulism vaccine in protecting ducks (mallard and northern pintail).
  • To assess the vaccine's effectiveness when used as a therapeutic agent in conjunction with antitoxin during botulism outbreaks.

Main Methods:

  • Ducks were immunized subcutaneously with a type C botulism vaccine.
  • Immunized and control ducks were challenged with varying doses of botulinum toxin at different time points post-immunization.
  • In a therapeutic model, ducks exhibiting clinical signs of botulism were treated with antitoxin, with half also receiving the vaccine.

Related Experiment Videos

  • Treated birds were subsequently re-challenged with botulinum toxin.
  • Main Results:

    • Vaccination significantly reduced morbidity and mortality in ducks challenged 10-15 days post-immunization.
    • Protection was observed up to 90 days post-immunization in mallards.
    • When used therapeutically with antitoxin, immunization did not improve immediate recovery but significantly reduced mortality upon subsequent toxin challenge.
    • Immunized birds showed significantly fewer clinical signs and lower mortality rates after the second challenge.

    Conclusions:

    • Subcutaneous immunization with a type C botulism vaccine can protect ducks against intoxication.
    • The vaccine demonstrates potential as an adjunct therapy for managing botulism outbreaks in avian populations.
    • Further research may explore optimal vaccination protocols for wild bird populations affected by botulism.